NCT07470489 2026-04-16
Zanzalintinib Plus Cemiplimab for the Treatment of BRAF Wild-Type Anaplastic Thyroid Cancer
M.D. Anderson Cancer Center
Phase 2 Not yet recruiting
M.D. Anderson Cancer Center
Radboud University Medical Center
Memorial Sloan Kettering Cancer Center
University of Michigan Rogel Cancer Center
National Cancer Centre, Singapore
Peking Union Medical College Hospital
Moonlight Bio, Inc
Vanderbilt-Ingram Cancer Center